<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074798</url>
  </required_header>
  <id_info>
    <org_study_id>CME ZOL - CTU2019078</org_study_id>
    <nct_id>NCT04074798</nct_id>
  </id_info>
  <brief_title>Hyperventilation in Patients With Chronic Low Back Pain</brief_title>
  <acronym>HELBP</acronym>
  <official_title>Hyperventilation in Patients With Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZOL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low back pain (LBP) is the leading cause of disability worldwide. Impaired postural control
      is a key factor in the development and maintenance of LBP. Moreover, the prevalence of LBP is
      associated with impairments in diaphragm function, symptoms of dyspnea, and dysfunctional
      breathing. However, the association between LBP (and more specifically postural control) and
      hyperventilation remains unknown. The main objective of this project is to investigate
      whether the presence of recurrent non-specific LBP is related to the presence of
      hyperventilation, when classified either objectively by decreased carbon dioxide values
      (demonstrating hypocapnia) or by symptoms while showing normal carbon dioxide values.
      Moreover, the investigators will explore whether psychosocial factors play a role in this
      relation. Subsequently, the investigators will examine whether hyperventilation in LBP
      patients is related to impaired postural control, and more specifically to a decreased
      postural contribution of the diaphragm.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients with low back pain are compared to patients without low back pain (healthy controls).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nijmegen questionnaire</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nijmegen questionnaire</measure>
    <time_frame>Day 4</time_frame>
    <description>Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PetCO2</measure>
    <time_frame>Day 1</time_frame>
    <description>End-tidal carbon dioxide pressure measured with a capnograph</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postural control</measure>
    <time_frame>Day 1</time_frame>
    <description>upright standing balance measured by center of pressure by force plate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Breathing frequency</measure>
    <time_frame>Day 1</time_frame>
    <description>amount of breaths per minute, inspiratory and expiratory time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breathing pattern (abominal and thoracic)</measure>
    <time_frame>Day 1</time_frame>
    <description>abdominal or thoracic contribution to one breath measured by respiratory inductance plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic thickness and thickening</measure>
    <time_frame>Day 1</time_frame>
    <description>The thickness of the diaphragm at Total Lung Capacity and Residual Volume, and the difference between thicknesses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragmatic motion</measure>
    <time_frame>Day 1</time_frame>
    <description>amount of displacement of the diaphragm between Total Lung Capacity and Residual Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale for low back pain (NRS)</measure>
    <time_frame>Day 1</time_frame>
    <description>11 point Likert scale evaluating severity/intensity of back pain, ranging from 0 (no pain) to 11 (worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index version 2.1a (ODI-2.1a)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating disability. 10 items Total score range from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-item Short form Health Survey (SF-12)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating physical and mental components of health related quality of life. 12 items. Total score range 12-56.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear Avoidance Component Scale (FACS)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating fear-avoidance related to pain. 20 items Total score range from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tampa Scale for Kinesiophobia (TSK)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating kinesiophobia related to pain. 17 items. Total score range from 17-68</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale (PCS)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating catastrophizing. 13 items, 5 point Likert scale. Total score 0-52</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Controllability and Predictability Questionnaire (NCP-Q)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating the need for being able to control and predict situations. 15 items, 5 point Likert scale. Total score range 15 - 75</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive And Negative Affect Schedule (PANAS)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating positive and negative affect. 10 items positive affect, 10 items negative affect, 5 point Likert scale. Total score range per affect: 10 - 50</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Solutions Questionnaire (PaSoL)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating assimilative and accommodative responses to problems associated with pain. 14 items, 7 point Likert scale. Total score range 0 - 84</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toronto Alexithymia Scale 20 (TAS-20)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating characteristics linked to alexithymia. 20 items, 3 factors. Total score range 20 - 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interoceptive Awareness Questionnaire (IAQ)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating adaptive and maladaptive body awareness. 19 items, 5 point Likert scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fremantle Back Awareness Questionnaire (FreBAQ)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating back specific perceptual awareness. 9 items, 5 point Likert scale. Total score range 0-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vragenlijst belastende ervaringen (VBE) - short version</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating aversive experiences in adult life. 11 items should be scored with yes or no. If yes a score on a 5 point Likert scale should be given.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Perfectionism Scale (MPS)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating adaptive and maladaptive perfectionism. 35 items, 5 point Likert scale. Total score range 35 - 175</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionnaire - Short Form (IPAQ-SF)</measure>
    <time_frame>Day 1</time_frame>
    <description>Questionnaire evaluating subjective level of physical activity. 7 questions regarding amount of time spent on certain activities.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1</time_frame>
    <description>ECG measurement to determine heart rate variability</description>
  </other_outcome>
  <other_outcome>
    <measure>Skin temperature</measure>
    <time_frame>Day 1</time_frame>
    <description>The temperature measured at the level of the skin, stress physiological measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Skin conductance</measure>
    <time_frame>Day 1</time_frame>
    <description>The resistance / conductance of the skin, stress physiological measure</description>
  </other_outcome>
  <other_outcome>
    <measure>Activity of abdominal muscles</measure>
    <time_frame>Day 1</time_frame>
    <description>The amount of muscle activation measured by electromyography</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Low Back Pain, Recurrent</condition>
  <condition>Hyperventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with low back pain</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>assessment of hyperventilation, postural control and psychological behavior</intervention_name>
    <description>assessment of hyperventilation, postural control and psychological behavior</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with low back pain</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria Patients:

          -  Chronic primary low back pain (&gt;12 weeks) as diagnosed by a medical doctor

        Inclusion Criteria Healthy controls:

          -  No low back pain

        Exclusion Criteria:

          -  Insufficient understanding of Dutch language

          -  Previous spinal surgery

          -  Chronic Obstructive Lung Disease, Interstitial Lung Disease, pulmonary vascular
             disease, asthma except for exertional asthma

          -  Acute cardiovascular or gastrointestinal disorders

          -  Neuromuscular disease interfering with normal lower limb or trunk functioning

          -  Acute pain or secondary chronic pain

          -  Pregnant and lactating women

          -  Major psychiatric conditions

          -  Acute lower limb problems

          -  Vestibular disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lotte Janssens, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlotte Amerijckx, MSc, PT</last_name>
    <phone>+3211 26 92 10</phone>
    <email>Charlotte.Amerijckx@uhasselt.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katleen Bogaerts, PhD, PT</last_name>
    <email>Katleen.Bogaerts@uhasselt.be</email>
  </overall_contact_backup>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 28, 2019</study_first_submitted>
  <study_first_submitted_qc>August 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2019</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Lotte Janssens</investigator_full_name>
    <investigator_title>Prof. dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperventilation</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

